Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Xilio Therapeutics, Inc. | StockGist | StockGist

Companies
XLO
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings XLOSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Xilio Therapeutics, Inc.

Filed Nov 14, 2025

Accepted Nov 13, 2025, 7:00 PM ET

CIK 0001840233

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

8,000,000

Reporting Person

Xilio Therapeutics, Inc.

Person Type

PN

CUSIP: 98422T100

Amendment History

10 filings

SCHEDULE 13G
Original
Dec 11, 20250001104659-25-120365
SCHEDULE 13G/A
Amendment 1
Dec 19, 20240001123292-24-000396
SCHEDULE 13G/A
Amendment 2
May 15, 20250001172661-25-002077
SCHEDULE 13G/A
Amendment 3
Aug 14, 20250001123292-25-000366
SCHEDULE 13G/A
Amendment 4
Aug 14, 20250001415889-25-021802
SCHEDULE 13G/A
Amendment 5
Viewing
Nov 14, 20250000902664-25-004986
SCHEDULE 13G/A
Amendment 6
Feb 12, 20260001123292-26-000166
SCHEDULE 13G/A
Amendment 7
Feb 13, 20260001231919-26-000149
SCHEDULE 13G/A
Amendment 8
Feb 17, 20260001104659-26-015985
SCHEDULE 13G/A
Amendment 9
Latest
Feb 17, 20260001193125-26-054804

Key Facts

Shares Owned

8,000,000

Recent Filings

Xilio Therapeutics, Inc.1 weeks ago

Xilio Therapeutics, Inc.1 weeks ago

Xilio Therapeutics, Inc.3 weeks ago

Xilio Therapeutics, Inc.3 weeks ago

Xilio Therapeutics, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice